Stock Chart
MLTX
Type: SELL wallstreet
Strike: $25
Premium: $4.05
Expiry: Jan 15, 2027
Target: $24
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Key Statistics
More MLTX Analysis
This MLTX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MLTX's price movements with trendlines, gamma walls, and key support/resistance levels.